IRadimed Corporation (IRMD)
USD 49.54
(-3.54%)
USD 49.54
(-3.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 92.15 Million USD | 7.77% |
| 2022 | 85.51 Million USD | 3.17% |
| 2021 | 82.88 Million USD | 16.62% |
| 2020 | 71.06 Million USD | 6.5% |
| 2019 | 66.72 Million USD | 37.75% |
| 2018 | 48.44 Million USD | 24.17% |
| 2017 | 39.01 Million USD | 4.89% |
| 2016 | 37.19 Million USD | 5.53% |
| 2015 | 35.24 Million USD | 51.2% |
| 2014 | 23.3 Million USD | 233.62% |
| 2013 | 6.98 Million USD | 25.79% |
| 2012 | 5.55 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 94.24 Million USD | 4.78% |
| 2024 Q1 | 88.01 Million USD | -4.49% |
| 2024 Q2 | 89.94 Million USD | 2.2% |
| 2023 Q3 | 87.4 Million USD | 7.34% |
| 2023 Q4 | 92.15 Million USD | 5.43% |
| 2023 Q2 | 81.43 Million USD | 7.68% |
| 2023 Q1 | 75.62 Million USD | -11.57% |
| 2023 FY | 92.15 Million USD | 7.77% |
| 2022 Q1 | 72.39 Million USD | -12.65% |
| 2022 Q4 | 85.51 Million USD | 7.5% |
| 2022 FY | 85.51 Million USD | 3.17% |
| 2022 Q3 | 79.54 Million USD | 5.05% |
| 2022 Q2 | 75.72 Million USD | 4.6% |
| 2021 Q3 | 78.39 Million USD | 3.73% |
| 2021 Q2 | 75.57 Million USD | 4.7% |
| 2021 FY | 82.88 Million USD | 16.62% |
| 2021 Q4 | 82.88 Million USD | 5.72% |
| 2021 Q1 | 72.18 Million USD | 1.58% |
| 2020 Q4 | 71.06 Million USD | 0.91% |
| 2020 FY | 71.06 Million USD | 6.5% |
| 2020 Q3 | 70.42 Million USD | 2.33% |
| 2020 Q2 | 68.82 Million USD | 0.67% |
| 2020 Q1 | 68.36 Million USD | 2.46% |
| 2019 Q2 | 56.84 Million USD | 4.47% |
| 2019 Q3 | 62.57 Million USD | 10.07% |
| 2019 Q4 | 66.72 Million USD | 6.64% |
| 2019 FY | 66.72 Million USD | 37.75% |
| 2019 Q1 | 54.41 Million USD | 12.33% |
| 2018 Q3 | 46.81 Million USD | 9.29% |
| 2018 Q2 | 42.83 Million USD | 6.39% |
| 2018 Q4 | 48.44 Million USD | 3.48% |
| 2018 FY | 48.44 Million USD | 24.17% |
| 2018 Q1 | 40.26 Million USD | 3.2% |
| 2017 Q1 | 37.41 Million USD | 0.6% |
| 2017 Q4 | 39.01 Million USD | 2.88% |
| 2017 FY | 39.01 Million USD | 4.89% |
| 2017 Q3 | 37.91 Million USD | 2.92% |
| 2017 Q2 | 36.84 Million USD | -1.53% |
| 2016 Q3 | 35.48 Million USD | 9.71% |
| 2016 Q4 | 37.19 Million USD | 4.81% |
| 2016 Q1 | 33.45 Million USD | -5.09% |
| 2016 FY | 37.19 Million USD | 5.53% |
| 2016 Q2 | 32.34 Million USD | -3.3% |
| 2015 FY | 35.24 Million USD | 51.2% |
| 2015 Q2 | 28.76 Million USD | 10.57% |
| 2015 Q1 | 26.01 Million USD | 11.59% |
| 2015 Q4 | 35.24 Million USD | 13.51% |
| 2015 Q3 | 31.05 Million USD | 7.96% |
| 2014 Q1 | 7.75 Million USD | 11.04% |
| 2014 Q3 | 22.41 Million USD | 125.55% |
| 2014 FY | 23.3 Million USD | 233.62% |
| 2014 Q4 | 23.3 Million USD | 4.01% |
| 2014 Q2 | 9.93 Million USD | 28.07% |
| 2013 FY | 6.98 Million USD | 25.79% |
| 2013 Q4 | 6.98 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 5.55 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -193.809% |
| BrainsWay Ltd. | 62.97 Million USD | -46.345% |
| Cerus Corporation | 197.74 Million USD | 53.397% |
| Envoy Medical, Inc. | 7.64 Million USD | -1106.232% |
| electroCore, Inc. | 16.38 Million USD | -462.373% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1098.077% |
| IceCure Medical Ltd | 16.41 Million USD | -461.585% |
| Inogen, Inc. | 326.19 Million USD | 71.748% |
| OrthoPediatrics Corp. | 449.58 Million USD | 79.502% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -237.939% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -455.86% |
| MaxCyte, Inc. | 268.27 Million USD | 65.649% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1038.107% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2437.396% |
| Orthofix Medical Inc. | 925.31 Million USD | 90.041% |
| PAVmed Inc | 33.11 Million USD | -178.257% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 35.758% |
| RxSight, Inc. | 182.55 Million USD | 49.517% |
| Sight Sciences, Inc. | 166.65 Million USD | 44.701% |
| SI-BONE, Inc. | 230.42 Million USD | 60.006% |
| TELA Bio, Inc. | 78.04 Million USD | -18.076% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 63.417% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -758.864% |
| Acutus Medical, Inc. | 53.96 Million USD | -70.786% |
| Talis Biomedical Corporation | 98.34 Million USD | 6.288% |
| Spectral AI, Inc. | 10.69 Million USD | -761.916% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 57.852% |
| CVRx, Inc. | 115.22 Million USD | 20.024% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -57.099% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2858.222% |
| Bioventus Inc. | 810.91 Million USD | 88.635% |
| Venus Concept Inc. | 93.65 Million USD | 1.599% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -258.236% |
| LivaNova PLC | 2.42 Billion USD | 96.207% |
| 908 Devices Inc. | 202.98 Million USD | 54.599% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 88.555% |
| Nemaura Medical Inc. | 14.56 Million USD | -532.8% |
| NeuroPace, Inc. | 107.65 Million USD | 14.394% |
| LENSAR, Inc. | 69.58 Million USD | -32.437% |
| Apyx Medical Corporation | 79.24 Million USD | -16.3% |
| Cutera, Inc. | 346.29 Million USD | 73.388% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -119.336% |
| BioSig Technologies, Inc. | 1.79 Million USD | -5025.478% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 65.948% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -116.02% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.563% |
| Axonics, Inc. | 719.92 Million USD | 87.199% |
| Outset Medical, Inc. | 313.8 Million USD | 70.632% |
| IRIDEX Corporation | 34.43 Million USD | -167.616% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 77.229% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1654.018% |
| INVO Bioscience, Inc. | 20.88 Million USD | -341.196% |
| Telesis Bio, Inc. | 70.41 Million USD | -30.883% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 40.198% |
| Varex Imaging Corporation | 1.24 Billion USD | 92.625% |
| Quipt Home Medical Corp. | 247.4 Million USD | 62.751% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -889.861% |
| Pulmonx Corporation | 178.95 Million USD | 48.502% |
| Dynatronics Corporation | 25.94 Million USD | -255.259% |
| Modular Medical, Inc. | 13.8 Million USD | -567.459% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -759.104% |
| Semler Scientific, Inc. | 78.06 Million USD | -18.05% |
| InMode Ltd. | 863.28 Million USD | 89.325% |
| Bruker Corporation | 4.24 Billion USD | 97.832% |
| Cytosorbents Corporation | 53.26 Million USD | -73.029% |
| DexCom, Inc. | 6.26 Billion USD | 98.529% |
| Align Technology, Inc. | 6.08 Billion USD | 98.485% |
| Viveve Medical, Inc. | 25.91 Million USD | -255.637% |
| ZimVie Inc. | 1.2 Billion USD | 92.354% |
| Movano Inc. | 9.42 Million USD | -878.199% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 81.482% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2437.396% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -57.099% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 90.326% |
| Profound Medical Corp. | 43.68 Million USD | -110.949% |
| Insulet Corporation | 2.58 Billion USD | 96.439% |
| enVVeno Medical Corporation | 48.63 Million USD | -89.485% |
| Surmodics, Inc. | 185.73 Million USD | 50.382% |
| iCAD, Inc. | 41.41 Million USD | -122.503% |
| Nuwellis, Inc. | 9.77 Million USD | -843.256% |
| Biotricity, Inc. | 5.94 Million USD | -1450.764% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 78.724% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1017.588% |
| InspireMD, Inc. | 47.64 Million USD | -93.431% |
| PAVmed Inc. | 33.11 Million USD | -178.257% |
| BIOLASE, Inc. | 35.1 Million USD | -162.546% |
| Beyond Air, Inc. | 56.96 Million USD | -61.788% |
| FONAR Corporation | 214.24 Million USD | 56.986% |
| AxoGen, Inc. | 196.82 Million USD | 53.179% |
| Vivani Medical, Inc. | 45.79 Million USD | -101.227% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 67.255% |
| Inari Medical, Inc. | 674.23 Million USD | 86.332% |
| UFP Technologies, Inc. | 404.13 Million USD | 77.197% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -293.854% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -869.746% |
| Tenon Medical, Inc. | 6.34 Million USD | -1352.421% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -879.654% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 11.087% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.005% |
| Sintx Technologies, Inc. | 15.36 Million USD | -499.779% |
| NanoVibronix, Inc. | 6.67 Million USD | -1280.823% |
| Quanterix Corporation | 425.01 Million USD | 78.317% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -889.861% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -71.527% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 94.722% |
| TransMedics Group, Inc. | 706.04 Million USD | 86.948% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -45.835% |
| NeuroMetrix, Inc. | 21.42 Million USD | -330.145% |
| Hyperfine, Inc. | 94.19 Million USD | 2.169% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 65.695% |
| Biomerica, Inc. | 9.25 Million USD | -895.852% |
| Bone Biologics Corporation | 3.73 Million USD | -2365.542% |
| AVITA Medical, Inc. | 144.33 Million USD | 36.153% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1792.893% |
| Silk Road Medical, Inc | 265.3 Million USD | 65.265% |